INNOBIO FUND
InnoBio is a French venture capital fund of €140 million, managed by CDC Enterprises (www.cdcentreprises.fr) and for 37 per cent subscribed by the FSI and leading international pharmaceutical companies in France. The fund makes direct equity and quasi-equity investments in companies that provide innovative technological products and services in the healthcare market.
INNOBIO FUND
Status:
Active
Similar Organizations
PKO VC
PKO VC is a venture capital fund established by the largest Polish bank PKO Bank Polski
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-07 | Diotheris | InnoBio Fund investment in Seed Round - Diotheris | N/A |
| 2018-08-09 | Millendo Therapeutics | InnoBio Fund investment in Venture Round - Millendo Therapeutics | 30 M USD |
| 2017-03-20 | Advicenne | InnoBio Fund investment in Venture Round - Advicenne | 16 M EUR |
| 2017-02-24 | TxCell | InnoBio Fund investment in Post-IPO Equity - TxCell | 11 M EUR |
| 2015-01-21 | Sensorion | InnoBio Fund investment in Venture Round - Sensorion | 4 M EUR |
| 2013-11-25 | Pixium Vision | InnoBio Fund investment in Series A - Pixium Vision | 15 M EUR |
| 2013-04-24 | Genticel | InnoBio Fund investment in Series D - Genticel | 18.2 M EUR |
| 2012-12-18 | Poxel | InnoBio Fund investment in Series B - Poxel | 13 M EUR |
| 2012-11-26 | TxCell | InnoBio Fund investment in Series C - TxCell | 12.4 M EUR |
| 2011-01-05 | DBV Technologies | InnoBio Fund investment in Series C - DBV Technologies | 25.5 M USD |
More informations about "InnoBio Fund"
InnoBio Fund - Crunchbase Investor Profile
Sub-Organization of . CDC Enterprises . Founded Date 2009; Operating Status Active; Investor Type Government Office, Venture Capital Investment Stage Early Stage Venture, Late Stage Venture Number of Exits . obfuscated. obfuscated. …See details»
InnoBio Fund - Investments, Portfolio & Company Exits - Crunchbase
Mar 14, 2023 InnoBio Fund has invested in Millendo Therapeutics on Mar 14, 2023. This investment - Venture Round - Millendo Therapeutics - was valued at . obfuscated. obfuscated. …See details»
Biotech and Medtech VC funds - Bpifrance.com
Innobio is a €173m venture capital fund launched in 2009 focused on early- and mid-stage biotech and medtech start-ups.Its LPs are Bpifrance and nine major pharmaceutical …See details»
InnoBio Fund: Performance - PitchBook
InnoBio Fund has made numerous investments in companies like ENYO Pharma, Alentis Therapeutics, and Tridek-One within the Drug Discovery industry. What has InnoBio Fund …See details»
INNOBIO FUND
The fund participates in the capital of companies on a minority basis, as a “lead” or “co-lead”. Objectives : The main objective of the fund is to invest directly in equity and quasi-equity in the …See details»
InnoBio Portfolio Investments, InnoBio Funds, InnoBio Exits - CB …
InnoBio is a French venture capital fund, managed by CDC Entreprises subscribed by the FSI and leading international pharmaceutical companies established in France, such as sanofi-aventis, …See details»
InnoBio Fund (Bpifrance) - life-sciences-europe.com
Nov 17, 2009 Organisation › Details InnoBio Fund (Bpifrance) https://www.bpifrance.fr ... InnoBio is a € 173 million venture capital fund managed by Bpifrance, which is also an investor in the …See details»
Innobio 2 Fund: Performance - PitchBook
Nov 12, 2024 Innobio 2 Fund is a 2018 vintage early stage venture capital fund managed by CDC Enterprises and Bpifrance. The fund is located in Paris, France and will invest in France. …See details»
InnoBio Fund - raizer.app
InnoBio is a French venture capital fund. Learn which startups InnoBio Fund invests in, number of investmenst, exits, and contact info to pitch your startup.See details»
InnoBio Fund — 14 Investments, Performance analytics, Stats — …
The usual things for fund are deals in the range of 10 - 50 millions dollars. This InnoBio Fund works on 41 percentage points more the average amount of lead investments comparing to …See details»
InnoBio Fund - Updates, News, Events, Signals & Triggers
InnoBio is a French venture capital fund. Start Free Trial . Chrome ExtensionSee details»
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for ...
This infusion of capital, supported by new investor Bpifrance (through its InnoBio 2 fund), and existing backers Khosla Ventures and Seventure Partners (with Health For Life Capital™), …See details»
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for ...
Dec 5, 2023 InnoBio 2 is an investment fund dedicated to life sciences, managed by Bpifrance, which is also one of the LPs alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen, Servier, …See details»
Egle Therapeutics Raises 40 Million - Business Wire
Oct 22, 2021 InnoBio 2 is an investment fund dedicated to life sciences, managed by Bpifrance, which is also one of the LPs alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen, Servier, …See details»
France: Bpifrance establishes fund with Sanofi to invest in ...
On 4 February 2019, Bpifrance launched the InnoBio 2 fund with the global biopharmaceutical company Sanofi headquartered in France. The fund has a total initial value of EUR 135 million …See details»
Ona Therapeutics Raises €30M in Series A Financing - PR Newswire
Jun 16, 2020 InnoBio 2 is an investment fund dedicated to life sciences, managed by Bpifrance, which is also one of the LPs alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen, Servier …See details»
GamaMabs Pharma, new company specializing in oncology
The first equity funding round led by BpiFrance through Innobio fund, next to IRDINov and IXO Private Equity totalizes euros 3.1M. Paris, France, 30 September 2013 – The biotechnologies …See details»
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for ...
Dec 5, 2023 InnoBio 2 fund), and existing investors Khosla Ventures and Seventure Partners. • Funding expected to generate proof of concept clinical data in patients. Paris, FRANCE – …See details»
France unveils $153M public-private Innobio 2 fund to boost
PARIS – Bpifrance and Sanofi SA, of Paris, reported the launch of Innobio 2, an investment fund worth $153 million that is slated to back life sciences. BioWorld. Popular Stories. Today's news …See details»
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for ...
Dec 5, 2023 InnoBio 2 is an investment fund dedicated to life sciences, managed by Bpifrance, which is also one of the LPs alongside Sanofi, Boehringer Ingelheim, Takeda, Ipsen, Servier, …See details»